Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Search & Filter

Enter one or more words in to the search box and press Enter.
With each additional filter selection requires the articles to have each of the categories selected.

  • Filter by Section

  • Filter by Author

New HIV treatment posts positive trial data

October 6, 2022
admin
Results from a Phase 2a trial into ABX464 have shown a statistically-significant reduction of the HIV viral reservoir in the blood, biotechnology company ABIVAX has said.

New survey shows nearly 90% of GPs do not have concerns about poor flu vaccine efficacy in older adults

October 6, 2022
admin
Research among over 1,000 GPs conducted by medeConnect has found that many GPs are unaware of the recent findings by Public Health England (PHE) on the poor performance of existing flu vaccines in the most recent 2016/17 flu season in adults aged 65 years and over.

Older carers left to fill the gap as social care system crumbles

October 6, 2022
admin
New figures from Age UK reveal the vast numbers of older carers being left to fill the gap as our social care system crumbles. Older carers now providing nearly 54 million hours of care a week in England.

Older women bearing the burden of a lifetime of lower pay and unequal working conditions

October 6, 2022
admin
Older women are more vulnerable to financial difficulties than older men, with both their employment history and family circumstances impacting on pension income and ability to save, according to a report  from the Centre for Ageing Better.

Breast cancer less likely to come back with more intensive chemo

October 6, 2022
admin
Giving chemotherapy in higher average doses reduces the risk of early stage breast cancer coming back, according to new unpublished results

medi launches new restless legs syndrome foot wrap

October 6, 2022
admin
medi, a leading manufacturer of medical devices, has introduced restiffic, a drug-free treatment for patients with restless legs syndrome (RLS), in the UK.

Breast cancer risk up to three times higher in women with gum disease

November 23, 2022
Rob Mair
New research has discovered that women who suffer from gum disease are up to three times more likely to develop breast cancer.

Tresiba reduces hypoglycaemia regardless of blood sugar level

October 6, 2022
admin
People with either type 1 or type 2 diabetes treated with Tresiba had fewer episodes of low blood sugar (hypoglycaemia) compared with people on insulin glargine U100 regardless of whether they had achieved blood sugar targets.

New foot wrap restiffic launched for restless legs syndrome

October 6, 2022
admin
medi, a leading manufacturer of medical devices, has introduced a drug-free treatment for patients with restless legs syndrome (RLS) in the UK called restiffic.

ESC slams TV show questioning role of statins in cardiovascular disease

October 6, 2022
admin
The European Society Cardiology (ESC) has denounced a recent re-broadcast of a misinformed television programme questioning the relationship between blood cholesterol levels and cardiovascular disease. 

New TB drugs possible with understanding of old antibiotic

October 6, 2022
admin
Tuberculosis, and other life-threatening microbial diseases, could be more effectively tackled with future drugs, thanks to new research into an old antibiotic by the University of Warwick and The Francis Crick Institute.

New asthma guidance from NICE could save £2 million a year

October 6, 2022
admin
New tests to help diagnose asthma and a change in how medicines are offered can help people take control of their asthma, NICE says in new guidance.

New research suggests type 1 diabetes could be more common in adults

October 6, 2022
admin
Type 1 diabetes could be more common in adults than previously believed, according to new Diabetes UK-funded research.

Heparin found to benefit people with COPD

October 6, 2022
admin
A drug used to thin blood has been found to also significantly improve the ability to breathe when inhaled by people with COPD, for which there is no cure.

New drug reduces migraine symptoms, trial data reveals

October 6, 2022
admin
The drug erenumab (AMG334) has shown €œsignificant and sustained€ efficacy in migraine prevention, data published in the New England Journal of Medicine and announced by Novartis and Amgen.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy